Follicle stimulating hormone as a predictor of ovarian response in women undergoing controlled ovarian hyperstimulation for IVF

被引:31
|
作者
Ashrafi, M
Madani, T
Tehranian, AS
Malekzadeh, F
机构
[1] Royan Inst, Dept Endocrinol & Female Infertil, Tehran, Iran
[2] Iran Univ, Akbar Abadi Hosp, Med Sci & Hlth Serv, Tehran, Iran
[3] Azad Univ Islam Med Sci, Tehran, Iran
关键词
controlled ovarian hyperstimulation; follicle stimulating hormone level at day 3; oocyte; in vitro fertilization; poor ovarian response;
D O I
10.1016/j.ijgo.2005.06.017
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To evaluate the effect of basal follicle stimulating hormone (FHS) level on ovarian response in women undergoing controlled ovarian hyperstimulation for in vitro fertilization. Methods: A descriptive and analytic study of 212 cycles of IVF chosen from about 2200 files of women treated at Royan Institute, Tehran, Iran, from 1991 to 1999. Treatment was started with intranasal or subcutaneous buserlin (0.5 cm(3)), on day 21 (long protocol). On day 2 of the next cycle, stimulation with human menopausal gonadotropin (hMG) was initiated. When the number and size of follicles were suitable, human chorionic gonadotropin (hCG) was given intramuscularly for ovulation induction, followed by oocyte retrieval 36 to 40 h later. Embryos were transferred about 48 to 72 h after oocyte retrieval. The women were assigned to 2 groups on the basis of day 3 serum FSH levels (>= 15 IU/mL, group 1 and < 15 IU/mL, group 2). Results: There were statistically significant differences between the 2 groups in number of follicles, number of oocytes retrieved and embryos transferred (lower in group 1), and level of serum luteinizing hormone and number of canceled cycles (higher in group 1). There were no statistical differences in number of ampoules of hMG used or age of patients. Conclusion: Day-3 serum FSH level was a predictor of ovarian response and IVF outcome in this study. (c) 2005 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:53 / 57
页数:5
相关论文
共 50 条
  • [41] Does the controlled ovarian stimulation increase the weight of women undergoing IVF treatment?
    Tso, Leopoldo O.
    Leis, Luciana
    Glina, Claudia G.
    Busso, Cristiano E.
    Romano, Rodrigo S.
    Busso, Newton E.
    Wonchockier, Roberta
    Glina, Sidney
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2021, 263 : 205 - 209
  • [42] Controlled ovarian hyperstimulation interventions in infertile women aged 40 years or older undergoing in vitro fertilization
    Geng, Lihong
    Li, Weihong
    Li, Xiaohong
    Qin, Lang
    Xiao, Zhun
    Li, Shangwei
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2009, 106 (03) : 193 - 197
  • [43] Comparison of the efficacy and safety of a new recombinant human follicle-stimulating hormone (DA-3801) with follitropin-α (Gonal-F®) in women undergoing controlled ovarian hyperstimulation for assisted reproductive technology
    Moon, Shin Yong
    Choi, Young Sik
    Ku, Seung-Yup
    Kim, Seok Hyun
    Choi, Young Min
    Kang, Inn Soo
    Kim, Chung Hoon
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2007, 33 (03) : 305 - 315
  • [44] Prediction of high ovarian response to controlled ovarian hyperstimulation: anti-Mullerian hormone versus small antral follicle count (2-6 mm)
    Aflatoonian, Abbas
    Oskouian, Homa
    Ahmadi, Shahnaz
    Oskouian, Leila
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2009, 26 (06) : 319 - 325
  • [45] A gonadotropin releasing hormone agonist trigger of ovulation with aggressive luteal phase support for patients at risk of ovarian hyperstimulation syndrome undergoing controlled ovarian hyperstimulation
    Liang, I-Ting
    Huang, Hong-Yuan
    Wu, Hsien-Ming
    Wang, Hsin-Shih
    Yu, Hsing-Tse
    Huang, Shang-Yu
    Chang, Chia-Lin
    Soong, Yung-Kuei
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2015, 54 (05): : 583 - 587
  • [46] Ovarian response to controlled ovarian hyperstimulation in women with cancer is as expected according to an age-specific nomogram
    Devesa, Marta
    Martinez, Francisca
    Coroleu, Buenaventura
    Rodriguez, Ignacio
    Gonzalez, Clara
    Nolasco Barri, Pedro
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2014, 31 (05) : 583 - 588
  • [47] Ovarian response prediction in controlled ovarian stimulation for IVF using anti-Mullerian hormone in Chinese women A retrospective cohort study
    Zheng, Haiyan
    Chen, Shiping
    Du, Hongzi
    Ling, Jiawei
    Wu, Yixuan
    Liu, Haiying
    Liu, Jianqiao
    MEDICINE, 2017, 96 (13)
  • [48] Dehydroepiandrosterone treatment in women with poor ovarian response undergoing IVF or ICSI: a systematic review and meta-analysis
    Zhang, Meixiang
    Niu, Wenbin
    Wang, Yu
    Xu, Jiawei
    Bao, Xiao
    Wang, Linlin
    Du, Linqing
    Sun, Yingpu
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2016, 33 (08) : 981 - 991
  • [49] Recombinant follicle-stimulating hormone versus human menopausal gonadotropin in the late follicular phase during ovarian hyperstimulation for in vitro fertilization
    Commenges-Ducos, M
    Piault, S
    Papaxanthos, A
    Ribes, C
    Dallay, D
    Commenges, D
    FERTILITY AND STERILITY, 2002, 78 (05) : 1049 - 1054
  • [50] Estradiol level on day 9 as a predictor of risk for ovarian hyperresponse during controlled ovarian hyperstimulation
    Ho, HY
    Lee, RKK
    Lin, MH
    Hwu, YM
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2003, 20 (06) : 222 - 226